– Mayo Clinic, University of Minnesota, and ChromaDex to Collaborate on Study – IRVINE, Calif., April 13, 2016 (GLOBE NEWSWIRE) — Thorne Research and ChromaDex Corp. (OTCQX:CDXC) announced today a research endeavor with Mayo Clinic and the University of Minnesota Clinical and Translational Science Institute, regarding a planned clinical study to assess the effect of Nicotinamide Riboside (NR) on brain NAD+ in college football players.  The randomized, placebo controlled, double-blind study will enroll healthy male collegiate football linemen, not having a history of more than 3 concussions.  Participants will take either 750 mg per day of Nicotinamide Riboside (NR) or […]